News

Evolent Health Plans $140 Million Offering to Enhance Capital Structure

Evolent Health Plans $140 Million Offering to Enhance Capital Structure

Evolent Health Plans Significant Convertible Note Offering

Evolent Health, Inc. (NYSE: EVH), a leader in innovative health care solutions for complex conditions, has unveiled plans to offer $140 million in convertible senior notes due in 2031. This strategic move is aimed at repurchasing existing notes and enhancing its Class A common stock position.

Details of the Convertible Notes Offering

The proposed offering includes not just the base $140 million but also allows initial purchasers an option to acquire an additional $20 million in notes. This move is contingent on market conditions and regulatory compliance, underscoring Evolent's commitment to maintaining flexibility within its financial strategies.

Utilization of Proceeds

Evolent is set to allocate up to $100 million from these proceeds to repurchase some of its 1.50% convertible senior notes maturing in 2025. Additionally, approximately $40 million is earmarked for repurchasing shares of its Class A common stock, improving shareholder value through strategic financial maneuvers.

Market Impact of the Stock Repurchase

In conjunction with the share repurchase, Evolent intends to buy back shares sold short by investors in private transactions at a pricing benchmark that reflects the last reported sale price on the offering date. This approach may influence the market dynamics of Evolent’s Class A common stock significantly.

Conversion Rights and Financial Terms

The notes will carry conversion rights allowing holders to convert into cash, shares of Evolent's common stock, or a mix of both. These rights can be exercised based on a conversion rate that will be finalized during the pricing of the notes. Interest is to be paid semiannually starting on February 15, 2026, extending until the maturity date set for August 15, 2031.

Termination of Conversion Rights

Subject to certain conditions, particularly around the stock price performance, Evolent holds the discretion to terminate conversion rights after August 20, 2026. This decision hinges on prior trading performance within specified periods, ensuring that holders remain informed about their options.

Potential Market Reactions

The interactions surrounding the repurchase of the 2025 Notes may lead to heightened trading activity in Evolent’s stock. Investors may react by adjusting their positions, leading to fluctuations in the stock price. The increased demand could enhance the overall market appeal of Evolent’s securities.

Regulatory Compliance and Investor Information

The notes and any common stock that may be issued upon conversion are not registered under the Securities Act or any applicable state laws, meaning they cannot be offered or sold absent registration or an exemption. This emphasizes Evolent's commitment to adhering to regulatory standards while engaging in business activities that benefit overall operations.

Overview of Evolent Health

Evolent Health is renowned for delivering healthcare solutions that improve health outcomes for those with complex medical conditions. With a national client base comprising leading payers and providers, Evolent is dedicated to making healthcare simpler, more effective, and accessible in today's fast-paced environment.

Frequently Asked Questions

What is the purpose of Evolent's convertible note offering?

The offering aims to raise capital to repurchase existing convertible notes and enhance the company's Class A common stock position.

How much is Evolent planning to raise through this offering?

Evolent intends to raise approximately $140 million, with an option to raise an additional $20 million.

What stock does Evolent Health focus on for repurchase?

Evolent will use part of the proceeds to repurchase its Class A common stock as well as certain outstanding convertible senior notes.

When will interest on the convertible notes be paid?

Interest on the notes will be paid semiannually beginning February 15, 2026.

Is the convertible note offering registered under the Securities Act?

No, the notes and the stock upon conversion are not registered and cannot be sold without compliance with legal regulations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Union Pacific Faces $98.8 Million Arbitration Tab

Updated Category News Views 143

A Missed Schedule Promise Got Very Expensive Railroad labor disputes can look like paperwork until the bill lands with a thud. Union Pacific is facing an estimated $98.8 million arbitration payout after a Special Board of Adjustments found that the carrier failed to implement a negotiated scheduling benefit for locomotive engineers. That is not loose change, and it is the...

Continue Reading
Travel Awards Spotlight Luxury Hospitality's Reach

Updated Category News Views 90

Hong Kong’s awards roll call reads less like a scorecard than a map of where premium travel wants its money and attention to go next. The 2026 World’s Travel & Hotel Awards, released November 20, cast a very wide net: heritage palaces, city hotels, beach retreats, airlines, cruise operators, tourism boards, restaurants, serviced apartments and a fair number of...

Continue Reading
Faex Health Adds Ebola and H. pylori AI Screening Tools

Updated Category News Views 82

A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...

Continue Reading
Lara Kirchner's Surgical Leadership Earns Recognition

Updated Category News Views 83

Surgical care gets judged in the quiet moments nobody puts on a plaque: a sterile instrument ready when it must be, a handoff done cleanly, a team that does not let a rushed schedule turn into a bad outcome. That is why Lara L. Kirchner's recognition as a Pinnacle Professional of the Year deserves a more serious look than the usual congratulatory confetti. Kirchner is...

Continue Reading
ECW Puts $52 Million Behind Learning Through Crisis

Updated Category News Views 66

A reserve fund for a classroom is not glamorous, but it may be the smartest detail in this whole $52 million commitment. Education Cannot Wait has announced support for more than 300,000 children in Lebanon, Myanmar and South Sudan, where war, flooding and displacement have ripped ordinary schooling apart. The money is meant to restore learning, provide catch-up classes...

Continue Reading
Nansha's Trade Pitch Has Numbers, but Questions Remain

Updated Category News Views 112

A Chilean cherry spending 22 days at sea can tell an investor plenty about where Guangzhou's Nansha District wants to sit in Asia-Pacific commerce. Not glamorous, no. But trade infrastructure rarely is until volumes pile up, routes deepen, and somebody else finds they cannot easily replicate the network. Nansha is using the expected 33rd APEC Economic Leaders' Meeting in...

Continue Reading
CVRx Lawsuit Puts Barostim Sales Claims Under Hard Scrutiny

Updated Category News Views 121

August 7 turned a compliance disclosure into a wrecking ball for CVRx shareholders. After the company revealed a Department of Justice civil investigative demand and cut its outlook, the stock dropped $3.55, or 60%, to close at $2.39. That is not a routine bad quarter getting punished. It is the market abruptly questioning whether the sales engine, the revenue it...

Continue Reading
Rock Gate Buys Aviation Niche Player Blast Deflectors

Updated Category News Views 167

Jet exhaust is not glamorous, but somebody has to keep it from battering everything nearby. Rock Gate Partners’ acquisition of Blast Deflectors, Inc. puts money behind one of those stubbornly unsexy industrial niches where engineering credibility matters far more than a flashy sales pitch. The transaction closed October 16, 2026, and Northborne Partners announced...

Continue Reading
Swim Readiness Depends on Skills, Not Birthdays Alone

Updated Category News Views 55

A child popping up calmly after a brief dunk tells you more than a birthday ever will. That is the sensible center of Woody Alpern's guidance for families weighing whether a child belongs in the next swim level. The Atlanta swim school expert's point is refreshingly free of the usual parental race: advancement is earned through repeatable skills, comfort, and judgment in...

Continue Reading
GEYOTO’s RE+ Debut Shows Demand, Not Yet Scale Proof

Updated Category News Views 39

Desert-colored booths do not pay invoices, but a nearly sold-out stash of spare units is a lot more useful than the usual trade-show applause. GEYOTO’s first RE+ appearance, held November 17–19 at the Las Vegas Convention Center, produced the kind of early evidence a young energy-products brand needs: people stopped, handled the equipment, asked questions, made...

Continue Reading

Top 5 Most Recently Viewed Articles

Beyond Finance Secures Legal Win with Permanent Injunction

Updated Category News Views 1608

Legal Victory for Beyond Finance Against Former Executive In a significant legal development, Beyond Finance has successfully secured a permanent injunction against its former Chief Marketing Officer, Grant Eckert. This ruling was handed down by a Texas court, illustrating a firm stance by Beyond Finance in upholding its non-competition agreements. Details of the Case The...

Continue Reading
Analyzing the Decline in Serve Robotics Inc's Short Interest

Updated Category News Views 174

Understanding Serve Robotics Inc's Short Interest Trends Serve Robotics Inc (NYSE: SERV) has recently reported a noticeable decline in its short interest, down by 6.79% from the previous report. As of the latest data, around 13.64 million shares have been sold short, representing 19.08% of all available shares for trading. Notably, it would take traders an average of 1.53...

Continue Reading
FAT Brands Stock Trend Analysis: 52-Week Low Challenges

Updated Category News Views 147

FAT Brands Faces Market Challenges at 52-Week Low In recent trading activities, FAT Brands Inc., trading under the ticker FATBB, has encountered significant market challenges, recently dropping to a 52-week low of $4.13. This recent low is indicative of the difficulties the company is facing amidst a shifting economic environment. Market Dynamics Affecting FAT Brands...

Continue Reading
Kraig Labs Leads the Charge in Revolutionary Silk Fabrication

Updated Category News Views 221

Kraig Labs: Pioneering Spider Silk Innovation In recent years, the realm of biotechnology has witnessed significant advancements, particularly in the production of specialized materials. Kraig Biocraft Laboratories, or Kraig Labs, stands at the forefront of this innovative field, redefining the future of spider silk. This biotechnology company has gained recognition for...

Continue Reading
The Safar Twins Unveil Stunning Short Film Resonance

Updated Category News Views 395

The Safar Twins Unveil a Captivating New Short Film Written and directed by interdisciplinary artist Parsa Afsharjavan, Resonance is an upcoming cinematic gem that promises to captivate audiences worldwide. This 30-minute short film, inspired by the intricate themes of duality and identity, is set to premiere in 2025 and navigate the global festival circuit. Introducing...

Continue Reading